Thus, in the present study, we investigated whether modulating STAT6 activity using a selective STAT6 inhibitor, AS1517499, influences the inflammatory response in zymosan-induced peritonitis by regulating PPARγ expression and activity. The gene discussed is PPARG; the disease is peritonitis.